Background: Presenting symptoms of multiple myeloma (MM) are vague and nonspecific.
Early detection poses a diagnostic challenge in primary care. We assessed whether clinical …

Background: Myeloma is a serious and usually fatal haematological malignancy with
reported mortality of 10–20% within the first 2 months of presentation. Symptoms are non …

Multiple myeloma (MM) often presents with unspecific symptoms and is challenging to
diagnose. We performed this DSMM/EMN-analysis via test-(retro-) and validation …

Delayed diagnosis is a common challenge in the management of multiple myeloma (MM).
This prospective interdisciplinary study evaluated symptoms and time to diagnosis (TTD) in …

Objectives Patients with multiple myeloma (MM) experience significant delays in diagnosis
due to non-specific symptomatology. The aim of this study was to characterise the frequency …

Increased attention to timely diagnosis motivated us to study 5483 patients diagnosed with
multiple myeloma using Medicare claims linked to tumor registries in the Surveillance …

Background Patients with myeloma experience the longest diagnostic delays compared with
patients with other cancers in the UK; 37% are diagnosed through emergency presentations …

We studied the medical histories of 127 patients diagnosed with multiple myeloma included
in a population-based registry of 945 patients with a paraprotein or multiple myeloma in the …

Purpose: To review the presenting signs and symptoms of multiple myeloma, its
pathophysiology, diagnostic evaluation, and treatment options. Data sources: A literature …

Multiple myeloma is the second most common hematologic malignancy in the United States
and the most common hematologic malignancy among Blacks/African Americans. Delay in …